logo

For the Inventor, By the Inventor

New Haven, MO, United States of America

S Christopher Bauer

This inventor holds 30 USPTO granted patents, plus 1 CIPO patent, primarily in Hematopoietic Growth Factors. Top assignees: G.d. Searle & Company, Pharmacia Corporation, G.d. Searle LLC. Active years: 1997-2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: S Christopher Bauer. Retrieved from https://idiyas.com/inventor/s-christopher-bauer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 30

% Patents Active = 100.0

 

Average Co-Inventor Count = 9.7

ph-index = 10

Forward Citations = 323(Granted Patents)


Company Filing History:

goldMedal19 out of 1,323 
 
G.d. Searle & Company
 patents
silverMedal2 out of 220 
 
Pharmacia Corporation
 patents
bronzeMedal1 out of 33 
 
G.d. Searle LLC
 patents
4. 8 out of 834,513 
Other
 patents

Years Active: 1997-2006

Loading Chart...
Loading Chart...
Areas of Expertise:
Hematopoiesis
IL-3 Variants
Fusion Proteins
Mutant Polypeptides
Ex-Vivo Expansion
Stem Cells
Therapeutic Methods
Colony Stimulating Factors
Recombinant Production
Multi-Lineage Production
Hematopoietic Disorders
Chimera Proteins
30 patents (USPTO):Explore Patents
1. 7091319 - IL-3 variant hematopoiesis fusion protein (2006-08-15),
2. 6730303 - Fused G-CSF and IL-3 proteins and uses thereof (2004-05-04),
3. 6479261 - Methods of using interleukin-3 (IL-3) mutant polypeptides for ex-vivo expansion of hematopoietic stem cells (2002-11-12),
4. 6458931 - Interleukin-3 (IL-3) multiple mutation polypeptides (2002-10-01),
5. 6440407 - Methods of ex-vivo expansion of hematopoietic cells using interleukin-3 (IL-3) multiple mutation polypeptides (2002-08-27),
6. 6436387 - Methods of ex-vivo expansion of hematopoietic cells using multivariant IL-3 hematopoiesis chimera proteins (2002-08-20),
7. 6413509 - Methods of ex-vivo expansion of hematopoietic cells using interleukin-3 mutant polypeptides with other hematopoietic growth factors (2002-07-02),
8. 6403076 - Compositions for increasing hematopoiesis with interleukin-3 mutants (2002-06-11),
9. 6379662 - Co-administration of interleukin-3 mutant polypeptides with CSF's for multi-lineage hematopoietic cell production (2002-04-30),
10. 6361977 - Methods of using multivariant IL-3 hematopoiesis fusion protein (2002-03-26),
11. 6361976 - Co-administration of interleukin-3 mutant polypeptides with CSF'S for multi-lineage hematopoietic cell production (2002-03-26),
12. 6153183 - Co-administration of interleukin-3 mutant polypeptides with CSF's or (2000-11-28),
13. 6132991 - Human interleukin-3 (IL-3) variant fusion proteins (2000-10-17),
14. 6093395 - Co-administration of interleukin-3 mutant polypeptides with CSF's for (2000-07-25),
15. 6074639 - Ex vivo expansion of hematopoietic cells using interleukin-3 (IL-3) (2000-06-13),

Title: S Christopher Bauer: A Pioneering Inventor in Hematopoietic Research

Introduction: S Christopher Bauer, located in New Haven, Missouri, is a distinguished inventor known for his significant contributions to the field of hematopoietic research. With an impressive portfolio of 30 patents, Bauer has made notable strides in the development of innovative medical therapies and scientific advancements.

Latest Patents: Among his latest patents, Bauer has developed the "IL-3 variant hematopoiesis fusion protein." This invention involves fusion molecules that consist of human interleukin-3 (hIL-3) variant proteins, which are functionally coupled to a second colony-stimulating factor, cytokine, or other interleukin variants. These hIL-3 variants feature unique amino acid substitutions and potential amino acid deletions at both the N- and C-termini. Additionally, his patent on "Fused G-CSF and IL-3 proteins and uses thereof" describes multi-functional hematopoietic receptor agonist proteins along with the methods of making and utilizing these proteins, showcasing Bauer's commitment to advancing medical treatments.

Career Highlights: Throughout his career, S Christopher Bauer has worked with prominent companies, including G.D. Searle & Company, which reflects his substantial impact on the industry. His inventive work has not only enriched scientific knowledge but has also paved the way for new therapeutic approaches in medicine.

Collaborations: Bauer has collaborated with fellow professionals such as John Patrick McKearn and Alan Michael Easton. These partnerships have fostered a creative environment for innovation, allowing for the successful development of groundbreaking solutions in health and medicine.

Conclusion: In summary, S Christopher Bauer stands out as a trailblazing inventor in the realm of hematopoietic research. With 30 patents to his name and a series of innovative inventions, he continues to influence the scientific community, driving forward the development of novel therapies for various medical conditions. His collaborative efforts further enhance the potential for future discoveries in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…